Adam Taich
CFO at 10x Genomics, Inc. (TXG)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 11SEC | TXG10x Genomics, Inc. | Sell Plan | 1,206361,526 held (−0%) | $63.68 | $77K | +26.6% |
| Sep 11SEC | TXG10x Genomics, Inc. | Sell Plan | 31,428330,098 held (−9%) | $64.31 | $2.0M | +25.4% |
| Sep 11SEC | TXG10x Genomics, Inc. | Sell Plan | 13,754316,344 held (−4%) | $65.26 | $898K | +23.6% |
| Aug 26SEC | TXG10x Genomics, Inc. | Sell | 17,166362,732 held (−5%) | $63.02 | $1.1M | +28.0% |
| May 27SEC | TXG10x Genomics, Inc. | Sell | 15,098379,898 held (−4%) | $24.44 | $369K | +230.0% |
| Feb 25SEC | TXG10x Genomics, Inc. | Sell | 8,968288,417 held (−3%) | $18.58 | $167K | +334.1% |
| Nov 25SEC | TXG10x Genomics, Inc. | Sell | 11,888297,385 held (−4%) | $19.00 | $226K | +324.5% |
- Sell
CFO Adam Taich sold $77K of TXG at $63.68 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Adam Taich sold $2.0M of TXG at $64.31 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Adam Taich sold $898K of TXG at $65.26 — pre-scheduled 10b5-1 plan sale.